We are live on ! Find out more
CRMD icon

CorMedix
CRMD

79 hedge funds and large institutions have $107M invested in CorMedix in 2021 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 26 increasing their positions, 21 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

96% more call options, than puts

Call options by funds: $4.2M | Put options by funds: $2.14M

57% more capital invested

Capital invested by funds: $68.7M → $107M (+$38.8M)

33% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 12

24% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 21

5% more funds holding

Funds holding: 75 → 79 (+4)

4.74% more ownership

Funds ownership: 28.83% → 33.56% (+4.7%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
79
Holders Change
+4
Holders Change %
+5.33%
% of All Funds
1.39%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
16
Increased
26
Reduced
21
Closed
12
Calls
$4.2M
Puts
$2.14M
Net Calls
+$2.06M
Net Calls Change
+$2.48M

Top Buyers

Rank Fund Capital Flow
1
CS
Credit Suisse
Switzerland
+$7.93M
2
BlackRock
BlackRock
New York
+$2.72M
3
Morgan Stanley
Morgan Stanley
New York
+$2.57M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$2.41M
5
State Street
State Street
Massachusetts
+$1.27M

Top Sellers

Rank Fund Capital Flow
1
EIM
Elliott Investment Management
Florida
-$2.19M
2
Two Sigma Investments
Two Sigma Investments
New York
-$1.13M
3
EI
EAM Investors
California
-$892K
4
Citadel Advisors
Citadel Advisors
Florida
-$582K
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$382K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$22.5M +$2.72M +258,101 +13%
Vanguard Group
2
Vanguard Group
Pennsylvania
$15.8M +$2.41M +228,962 +17%
EIM
3
Elliott Investment Management
Florida
$15.5M -$2.19M -207,851 -12%
CS
4
Credit Suisse
Switzerland
$7.53M +$7.93M +753,483 New
State Street
5
State Street
Massachusetts
$6.66M +$1.27M +120,805 +22%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$5.33M +$775K +73,613 +16%
Northern Trust
7
Northern Trust
Illinois
$3.35M -$179K -17,011 -5%
CAM
8
Cresset Asset Management
Illinois
$3.29M – – –
Morgan Stanley
9
Morgan Stanley
New York
$2.83M +$2.57M +244,444 +630%
N
10
Nuveen
North Carolina
$1.97M -$176K -16,741 -8%
Susquehanna International Group
11
Susquehanna International Group
Pennsylvania
$1.83M +$799K +75,898 +71%
Two Sigma Advisers
12
Two Sigma Advisers
New York
$1.77M -$382K -36,300 -17%
SC
13
Spinnaker Capital
Massachusetts
$1.75M +$1M +95,000 +118%
BCM
14
Bridgeway Capital Management
Texas
$1.53M +$579K +55,000 +56%
SPIA
15
Steward Partners Investment Advisory
New York
$1.38M +$667K +63,321 +84%
MS
16
Maven Securities
Jersey
$1.08M +$1.17M +111,065 New
Bank of New York Mellon
17
Bank of New York Mellon
New York
$947K -$45K -4,272 -4%
Charles Schwab
18
Charles Schwab
California
$825K +$21K +1,997 +2%
Bank of America
19
Bank of America
North Carolina
$670K +$376K +35,732 +114%
Deutsche Bank
20
Deutsche Bank
Germany
$640K +$429K +40,760 +176%
Goldman Sachs
21
Goldman Sachs
New York
$614K +$442K +42,022 +216%
OFG
22
Oxford Financial Group
Indiana
$608K – – –
JP Morgan Chase
23
JP Morgan Chase
New York
$583K -$288K -27,373 -32%
Ameriprise
24
Ameriprise
Minnesota
$542K +$345K +32,805 +153%
California Public Employees Retirement System
25
California Public Employees Retirement System
California
$521K – – –
1
2 3 4

CRMD Hedge Fund Activity: Q1 2021 in Review

79 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in CorMedix (CRMD) for Q1 2021, worth a combined $107M — up 57% from $68.7M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new CRMD positions and 12 closed out — a net gain of 4 holders — while 26 added to existing stakes and 21 trimmed.

The largest buyer was Credit Suisse, opening a new position worth an estimated $7.93M. The largest seller was Elliott Investment Management, cutting an estimated $2.19M.

  • 79 institutional investors held CorMedix (CRMD) as of Q1 2021, up from 75 in Q4 2020.
  • Funds reported $107M of CorMedix stock for Q1 2021, up 57% quarter-over-quarter.
  • 16 funds opened new CorMedix positions in Q1 2021 and 12 closed out, a net change of +4 holders.
  • The largest CorMedix buyer in Q1 2021 was Credit Suisse, an estimated $7.93M added.
  • The largest CorMedix seller in Q1 2021 was Elliott Investment Management, an estimated $2.19M sold.

Based on aggregated 13F filings for Q1 2021.